Roman Loonis
Associate Medical Director, Clinical Sciences, Neurodegenerative Disorders Takeda Pharmaceutical
Seminars
Thursday 5th February 2026
Translatable Synaptic & Lipid Biomarkers for Early Parkinson’s: Insights from Longitudinal Multi-Modal Signatures
1:30 pm
- Identifying novel plasma lipid and synaptic protein biomarkers that change longitudinally in early Parkinson’s, enabling earlier detection and patient stratification
- Correlating these biomarkers with clinical progression and functional decline to enhance predictive power in trial endpoints
- Enabling tighter selection and more efficient monitoring in clinical trials, reducing sample sizes and improving sensitivity to detect disease-modifying effects
